TOYO's $357M HJT Cell Plant Plan Adds Risk, No Margin Relief

What happened

TOYO announced a 1.5 GW HJT solar cell factory in Houston, co-located with its module site, requiring $357 million and 20 months. This aims to create an integrated domestic footprint and qualify as FEOC-compliant. However, the company faces a $70 million working capital deficit, going-concern warning, and heavy related-party dependence. The new capex will likely force dilutive financing, and shifting to HJT technology adds execution risk. This announcement does not address the core issues of weak margins, tariff exposure on Ethiopian exports, or unsustainable leverage.

Implication

Without proven profitability or self-funding, the additional $357M investment undermines balance sheet stability. The thesis remains bearish; attractive entry near $3.75 if trade policy and execution de-risk.

Thesis delta

The announcement reinforces our bearish view: TOYO is layering more capex onto a fragile balance sheet, increasing the likelihood of equity dilution. The shift to HJT adds technological uncertainty without improving margin visibility. Our STRONG SELL rating stands.